“The Buzz” Show: Evaxion Biotech (NASDAQ: EVAX) Reaches Milestone in EVX-01 Development
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Evaxion Biotech Reaches Milestone in EVX-01 Development” Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, reached an important milestone announcing today that it had enrolled its first patient in the global phase …
“The Buzz” Show: Evaxion Biotech (NASDAQ: EVAX) Reaches Milestone in EVX-01 Development Read More »